DarioHealth Corp. (DRIO) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 8 Buy.
The consensus price target is $16.00, representing an upside of 111.6% from the current price $7.56.
Analysts estimate Earnings Per Share (EPS) of $-22.47 and revenue of $0.03B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.61 vs est $-22.47 (beat +97.3%). 2025: actual $1.24 vs est $-11.49 (beat +110.8%). Analyst accuracy: 0%.
DRIO Stock — 12-Month Price Forecast
$16.00
▲ +111.64% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for DarioHealth Corp., the price target is $16.00.
The average price target represents a +111.64% change from the last price of $7.56.
DRIO Analyst Ratings
Buy
Based on 8 analysts giving stock ratings to DarioHealth Corp. in the past 3 months
EPS Estimates — DRIO
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.61
vs Est –$22.47
▲ 3,583.1% off
2025
Actual $1.24
vs Est –$11.49
▲ 1,026.8% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.
Revenue Estimates — DRIO
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.027B
vs Est $0.027B
▲ 0.9% off
2025
Actual $0.022B
vs Est $0.022B
▼ 0.3% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
